AI assistant
GENTEX CORP — Director's Dealing 2024
Feb 21, 2024
30893_dirs_2024-02-21_ce1adaa0-1936-40ab-874a-efe724d8eea1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2024-02-20
Reporting Person: Nash Kevin C (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-20 | Common Stock | A | 8726.00 | $0.00 | Acquired | 51456.00 | Direct |
| 2024-02-20 | Common Stock | F | 4191.00 | $35.0111 | Disposed | 47265.00 | Direct |
| 2024-02-20 | Common Stock | F | 2944.00 | $35.0111 | Disposed | 44321.00 | Direct |
| 2024-02-20 | Common Stock | M | 13500.00 | $22.94 | Acquired | 57821.00 | Direct |
| 2024-02-20 | Common Stock | S | 13500.00 | $33.0435 | Disposed | 44321.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-20 | Employee Stock Option (Right to buy) | $22.94 | M | 13500.00 | Disposed | 2028-02-15 | Common Stock (13500.00) | Direct |
Footnotes
F1: 8,726 shares are performance based shares where the total number of shares granted were based on long term performance incentives.
F2: This transaction was executed in multiple trades at prices ranging from $34.72 to $35.14. The price reported above reflects the weighted average price.
F3: This transaction was executed in multiple trades at prices ranging from $35.01 to $35.14. The price reported above reflects the weighted average price.
F4: These shares become exercisable as to 25% one year after date of grant and an additional 25% at each ensuing anniversary date.